Clinical Trial Update: Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial [Phase 2]

View source ↗

Summary

This completed Phase 2 randomized, double-blind, placebo-controlled pilot trial evaluated the safety of allogeneic adipose-derived mesenchymal stem cells in acu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Allogeneic adipose-derived mesenchymal stem cells (allogeneic adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Ischemic Stroke | Phase 2 | Status: COMPLETED